4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-040976
President and CEO sold 14,342 shares at $19.86 ($284,832)
- President and CEO acquired 14,342 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McCarthy Sean A. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-01 | Exercise or conversion : show line 1 in the form | +14,342 | $0.95 | $13,553 | 18,587 | D |
| 2017-11-01 | Sale : show line 2 in the form | −14,342 | $19.86 | $284,832 | 4,245 | D |
| Open-market sales · 14,342 sh · avg $19.86 · $284,832 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-11-01 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −14,342 | 119,293 | D |
Loading xslF345X03/doc1.xml…